Search

everythinglearnresearchcommunity

for

Search:↓

Hair cortisol is a reliable way to measure long-term stress in animals.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Bio-based electrospun fibers improve wound healing but face production and regulatory challenges.

Essential oils from Curcuma species, like turmeric, have compounds that can fight inflammation, cancer, and bacteria, and can also stimulate hair regrowth in bald males.

Different fibroblasts play key roles in skin healing and scarring.

Fibroblast Growth Factors (FGFs) are important for tissue repair and regeneration, influencing cell behavior and other factors involved in healing, and are crucial in processes like wound healing, bone repair, and hair growth.

Skin pigmentation varies due to genetics, UV exposure, and drugs, with treatments available but requiring medical advice.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

HPT axis hormones boost mitochondrial function and growth in hair follicles, potentially aiding hair health.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Disruptions in mammary stem cell division can lead to cancer, but targeting these processes might help treat breast cancer.

Heavily hunted wolves have higher stress and reproductive hormone levels.

Hidradenitis suppurativa is linked to various diseases like obesity, depression, arthritis, and Crohn's disease, but often occurs alone.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

New nanocarriers improve drug delivery for disease treatment.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Immune-epithelial interactions are crucial for tissue repair, but unchecked can cause diseases.

Effective vaccines and treatments are crucial for long-term COVID-19 control.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Improving topical drug delivery involves overcoming skin barriers and using personalized dosing to enhance effectiveness.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

Cold atmospheric plasma is a promising and safe treatment for various skin conditions.